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Intrarenal B cell infiltrates resembling secondary lymphoid
tissue have been found in several forms of inflammatory
kidney disease. Their role in renal inflammation is not well
defined, perhaps because B cell clusters have been regarded
as a single entity while being quite heterogeneous. Therefore
we characterized intrarenal lymphoid clusters of 32 patients
diagnosed with lupus nephritis and 16 with ANCA associated
nephritis. We identified four increasingly organized levels of
intrarenal aggregates from scattered B cells to highly
compartmentalized B cell clusters with central follicular
dendritic cell networks. Most B cells displayed a mature
non-antibody producing phenotype with antigen presenting
ability. In regions of B cell infiltration, expression of the
lymphoid chemokine BCA-1 was found in cells of a
dendritic-like morphology and most B cells expressed the
corresponding receptor CXCR5. Biopsies containing B cells
had significantly higher levels of BCA-1 mRNA expression
compared to those without, suggesting a role of BCA-1 and
CXCR5 for B cell infiltration into the kidney. Our study
proposes a new classification of B cell clusters in lupus and
ANCA associated nephritis which might help to study the
function of intrarenal B cell clusters in a more differentiated
manner.
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Recruitment of mononuclear cells into the kidney is a
common feature of immunologically mediated renal disease.
These infiltrates have long been believed to be composed of
mainly monocytes and T cells with little contribution from B
lymphocytes. This might be explained by the fact that B cells
have classically been considered to exert almost exclusively
long-range effects mostly via activation in secondary
lymphoid organs with subsequent proliferation and differ-
entiation into antibody-producing plasma cells. However, a
number of groups including our own have described the
previously unrecognized high prevalence of intrarenal B cells
in immunologically mediated diseases, including renal
transplant rejection and glomerulonephritis.1–12 This striking
presence in a growing number of renal pathologies has led to
many speculations on their functional importance. However,
in contrast to the role of T cells13 and monocytes,14,15 little
attention has been paid so far to renal infiltration of B cells as
modulators of inflammatory kidney disease. In many cases,
B cells appear in dense cluster-forming units with separate
B- and T-cell zones, being reminiscent of secondary
lymphoid tissues.16 It has been speculated that these
lymphoid aggregates undergo progressive organization over
time17 and might contribute to the persistence of and therapy
resistance in inflammatory processes. In renal transplant
rejection, B-cell clusters have been associated with steroid
resistance and poorer transplant survival.2,4–6 Some recent
studies reported different results,18–20 which emphasizes the
need for further investigation of the role of intrarenal B-cell
clusters.
One reason for these contradictory results could be that the
observed clusters, which have so far been regarded as one single
entity, are by no means a uniform population. The term
lymphoid cluster is rather simplistic, as it has become clear that
different grades of microanatomical organization exist in other
non-lymphoid tissues.17,21 Furthermore, some classical features
such as follicular dendritic cells (fDCs), high endothelial
venules, and germinal centers have not yet been found in the
kidney. Patients with highly organized intrarenal clusters might
therefore have been grouped with patients with merely nodular
B and T cell containing aggregates. No systematic micro-
anatomical analysis of the structure of intrarenal lymphoid
tissue has yet been performed. We thus aimed at investigating
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the organizational differences between intrarenal inflammatory
cell clusters, which could help to clarify the inconclusive results
from earlier studies. Furthermore, we investigated the possible
contribution of the lymphoid chemokine BCA-1/CXCL13 and
its specific receptor CXCR5 to B-cell infiltration and cluster
organization in the inflamed kidneys, as this chemokine/
chemokine receptor pair has been demonstrated to be an
important player in the formation and maintenance of ectopic
lymphoid tissue.22,23 As disease entities, we focused on lupus
nephritis (LN) and anti neutrophil cytoplasmic antibodies
(ANCA)-associated nephritis (AAN).
RESULTS
Tissue samples
In this study, renal biopsy samples were obtained from 32
patients with LN and from 16 patients with AAN from our
center. The diagnosis was based on light microscopy,
immunohistochemistry, and electron microscopy. Basic
clinical characteristics of the patients are shown in Tables
1a and 1b.
Microanatomical organization of inflammatory infiltrates
For the grading of cellular infiltrates, all biopsy samples from
patients with newly diagnosed lupus (n¼ 32) and AAN
(n¼ 14 Wegener’s granulomatosis and n¼ 2 microscopic
polyangiitis) were stained for CD3 as a pan T-cell marker,
CD20 as a pan B-cell marker, and CD21 as a marker for fDCs.
Thereby, it was possible to identify different organizational
levels of intrarenal aggregates that increasingly resembled
secondary lymphoid tissue. As B cells have been suggested to
be the main cellular players in lymphoid neogenesis,24 our
classification especially highlights their distribution patterns.
Scattered B cells and T cells were graded as 1. Nodular
aggregates without separate T- and B-cell zones, the second
organizational level, were graded as 2. Leukocyte clusters in
which distinct T- and B-cell regions had formed were graded
as 3. The highest organizational level clearly showed separate
B- and T-cell compartments with a central fDC network that
is a classical feature of germinal centers of lymph follicles in
secondary lymphoid tissue. These aggregates were graded as
4. Many specimens contained lymphocytic aggregates of
various grades. Fourteen biopsy samples from patients with
LN and four biopsy samples from AAN patients did not
contain any B cells and were graded as 0. The remaining 18
lupus and 12 AAN biopsy samples all contained areas of
scattered B-cell distribution according to grade 1. Type two
clusters without B- and T-cell compartmentalization were
found in 10 lupus and 5 AAN specimens. Grade 3 aggregates
with distinct B- and T-cell regions but without fDCs were
present in three lupus and two AAN biopsy samples. Type
Table 1a | Overview of patients with LN included in the study
Patient no. Age at biopsy/sex WHO type No. of B cells Grading Creatinine at biopsy (mg per 100 ml)
1 24/F V 0 0 0.8
2 26/F IV 0 0 1.3
3 22/M IV 0 0 1.0
4 23/F IV 0 0 1.0
5 31/F IV 0 0 2.0
6 27/F II 0 0 3.7
7 23/F IV 0 0 0.8
8 31/F IV 0 0 2.0
9 28/F III 0 0 0.9
10 18/F IV 0 0 1.3
11 28/F II 0 0 0.7
12 17/F III 0 0 0.8
13 47/F IV 0 0 0.7
14 26/M IV 0 0 1.6
15 19/F IV 2 1 2.2
16 53/F II 5 1 1.3
17 22/F III 9 1 1.5
18 33/F II 11 1 1.8
19 65/M II 25 1 2.2
20 28/F III 26 1 0.4
21 47/F IV 36 1 1.0
22 30/M II 39 1 2.6
23 23/M III 58 1, 2 3.1
24 24/F V 85 1, 2 0.7
25 43/M V 94 1, 2 1.4
26 67/F III 137 1, 2, 3 2.8
27 35/F IV 171 1, 2 1.4
28 34/F IV 194 1, 2, 4 1.8
29 34/F II 237 1, 2, 3, 4 1.0
30 65/M IV 259 1, 2, 3 2.5
31 63/M III 441 1, 2, 4 3.0
32 62/F V 564 1, 2, 4 0.9
F, female; M, male; WHO, World Health Organization.
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four clusters of the highest organizational level with clearly
separate B- and T-cell zones and a central fDC network were
found in four patients with LN and in one of the AAN
patients. Examples of all four types of organizational levels
from patients with LN are given in Figure 1. An overview is
given in Tables 1a and 1b.
Table 1b | Overview of patients with AAN included in the study
Patient no. Age at biopsy/sex AAN type No. of B cells Grading Creatinine at biopsy (mg per 100 ml)
33 39/M WG 0 0 7.6
34 87/F WG 0 0 4.8
35 24/M WG 0 0 5.6
36 73/M MP 0 0 1.4
37 39/M WG 14 1 1.6
38 59/F WG 15 1 2.5
39 25/F WG 18 1 2.6
40 80/M WG 25 1 4.2
41 59/F WG 27 1 2.9
42 54/M WG 29 1 5.8
43 49/M WG 29 1 2.2
44 63/M WG 80 1, 2 9.3
45 16/M WG 97 1, 2 5.6
46 50/M MP 176 1, 2, 3, 4 2.3
47 41/F WG 191 1, 2, 3 5.0
48 59/F WG 209 1, 2, 3 0.8
AAN, ANCA-associated nephritis; F, female; M, male; MP, microscopic polyangiitis; WG, Wegener’s granulomatosis.
CD3 CD21CD20
Grade 1
Grade 2
Grade 3
Grade 4
Figure 1 | Microanatomical organization of inflammatory infiltrates. Serial staining for CD3, CD20, and CD21 as a marker for fDCs
allowed classification into four different grades. Grade 1 aggregates consist of scattered T- and B-cell infiltrates (all original magnifications
 400). Grade 2 aggregates show a cluster-like structure but no T- and B-cell zones are evident (original magnification  200). In grade 3
aggregates, separate T- and B-cell areas are clearly distinguishable (original magnification  100). Grade 4 aggregates show a highly
organized structure with a central network of fDCs (original magnification  200).
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Characterization of B-cell subpopulations
Little is known about the characteristics of intrarenal B cells.
Therefore, we aimed at characterizing different B-cell subsets
according to the grade of maturation, antigen-presenting
ability, antibody production, and proliferative activity by
serial immunohistochemical staining of all biopsy specimens.
No CD10-positive pre-B cells were found in infiltrates in LN
or AAN (data not shown). CD27, which is presently the best
characterized marker for memory B cells25,26 and also serves
as a marker for active T cells, was localized almost exclusively
to the T-cell areas in both types of renal diseases (Figure 2a).
Staining for IgD, which is regularly present on non-memory
B cells (except germinal center B cells) and only rarely
found on memory B cells,27 is shown in Figure 3. B cells
outside the fDC containing germinal centers are IgD positive,
which identifies them as non-memory B cells. A significant
contribution of memory B cells to the infiltrates is there-
fore unlikely, even though the presence of some cells cannot
be ruled out. Staining for the plasma cell marker CD138
showed only positive cells in a scattered distribution in
most LN and AAN biopsy samples, whereas almost no
positive cells were found within grades 2–4 clusters (data not
shown). Proliferative activity was characterized by staining
for MIB-1, which showed strong positivity in the central
fDC and B cell containing networks in all grade 4 aggregates
of LN. All other regions in lupus and AAN, including the
single grade 4 cluster found in a specimen obtained from
one AAN patient, showed only few MIB-1-positive cells
(Figure 2a).
The pan T-cell marker CD5 has been shown to be
expressed by B cells of the B1 subset. These specific cells have
been reported to be more frequent in the blood of patients
with systemic lupus erythematosus28 and were linked to
autoantibody production independent of T-cell activation.29
However, immunohistochemistry for CD5 showed negative
results in B-cell areas and exclusive localization to T-cell
regions (Figure 2a).
Staining for CD62L as a marker for high endothelial
venules, which are the main routes of entry for lymphocytes
into lymph nodes, was negative in all kidney biopsies
including grade 4 aggregates (data not shown).
To assess whether B cells could function as intrarenal
antigen-presenting cells, we performed serial immunostain-
ing for CD20 and the major histocompatibility complex
(MHC) class II complex. MHC class II was abundantly
expressed by B cells as clearly seen at higher magnification
(Figure 2b) and, in addition, in a scattered distribution in
cells with monocyte/macrophage-like morphology. As
expected, T-cell regions stained negative for MHC class II
(data not shown). Serial immunohistochemical staining of
sections from a representative patient with LN is shown in
Figure 2a and b. The same results were found in the group of
patients with AAN. An example of a grade 4 cluster detected
in a sample from an AAN patient is shown in Figure 4.
Specificity of all antibodies used was validated in tissues from
human tonsils (data not shown).
Organization of lymphoid tissue in follow-up biopsies
For three patients with LN (nos. 2, 11, and 23) and one
patient with AAN (no. 39), follow-up biopsy specimens were
obtained after specific therapy. Interestingly in three of these
patients, intrarenal aggregates showed structures of a higher
organizational level at the later time points whereas in one
patient no change was noted. Infiltrates of the first biopsy
specimen from patient no. 2 were graded as 0 whereas grades
CD3
CD21
CD27
CD20
MIB-1
CD5
CD20 MHCII
MHCIICD20
Figure 2 | Immunohistochemical characterization of B cells.
(a) Serial staining of a grade 4 aggregate shows separate T- (CD3)
and B-(CD20) cell zones with a highly proliferating (MIB-1) central
fDC (CD21) network. CD27 as a marker for activated T cells,
and memory B cells is almost exclusively expressed in the T cell
zone. Similarly, CD5 as a marker for T cells and B1 cells is also only
found in the T-cell regions (all original magnifications  100).
(b) Serial staining for MHC class II complex shows positivity in
B-cell regions (original magnification  100). In the higher
magnification (original magnification  400), B cells can clearly be
identified as cellular source for MHC class II expression.
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1, 2, 3 and even highly organized grade 4 infiltrates were
present in the biopsy specimen obtained 10 years later from
the same patient. Similarly, the organization of infiltrates in
biopsy specimens from patient no. 11 had progressed from
grade 0 to grades 1 and 2 after 2 years. The grading level of
intrarenal infiltrates from patient no. 23 remained the same
(grade 2 at the first biopsy, grades 1 and 2 at follow-up biopsy
3 years later). In specimens from one patient with AAN
(no. 39), the organizational level of infiltrates had progressed
from initially grade 1 to grades 2 and 3 aggregates in the
follow-up biopsy 6 years later. An overview including
treatment modalities is given in Table 2.
Immunohistochemical staining of lymphoid chemokines in
renal biopsies
Immunohistochemical staining for the B-cell-specific lym-
phoid chemokine BCA-1/CXCL13 showed marked colocali-
zation with areas of B-cell infiltration in LN and AAN (Figure
5a and b) specimens. Areas without cellular infiltrates or
with substantial infiltration of inflammatory cells negative
for CD20 (mainly CD3-positive T cells) did not show any
BCA-1/CXCL13-positive staining. As Figure 5c illustrates,
the majority of BCA-1/CXCL13-producing cells showed a
dendritic cell-like morphology. Staining for CXCR5, the
specific receptor for BCA-1/CXCL13, revealed a strong
positivity exclusively in regions of CD20-positive B cells in
LN and AAN (Figure 6a and b). All other regions were
negative for CXCR5. Therefore, a strictly overlapping pattern
of CD20-positive infiltrating B cells with BCA-1/CXCL13 and
CXCR5 was observed. SLC/CCL21-positive staining was
found exclusively in endothelial cells of lymphatic vessels in
both types of nephritis. Neither apparent colocalization of
SLC/CCL21 with lymphoid aggregates nor cluster forming B
cells could be observed (data not shown). To determine
specificity of staining, immunohistochemistry in human
tonsil tissue was carried out (data not shown).
Intrarenal mRNA expression of BCA-1/CXCL13
To analyze intrarenal expression of the B-cell attracting
chemokine BCA-1/CXCL13, RNA was isolated from renal
biopsy specimens obtained from the 11 lupus patients with
the highest number of B cells (patient nos. 22–32) and 11
lupus patients devoid of intrarenal B cells (patient nos. 3, 4, 6,
8–15). mRNA analysis revealed a 107.7±34.1-fold higher
IgD
CD21
CD20
Figure 3 | Germinal centre B cells. Serial staining of a grade 4
aggregate shows that B cells (CD20) inside the CD21-positive
fDC containing central network lack IgD expression that is
characteristic for germinal center B cells. Furthermore, B cells
(CD20) outside the germinal center strongly express IgD, which
identifies them as non-memory B cells.
CD3 CD20
CD21
Figure 4 | Grade 4 cluster in AAN. As in lupus nephritis, a grade 4
cluster was also found in AAN that showed the identical
microanatomical organization and cellular composition. Clearly,
separable T- (CD3) and B-(CD20) cell zones with a central fDC
(CD21) network were found (original magnification  200).
Table 2 | Characterization of follow up biopsies
Patient
no.
Nephritis type first/
follow-up biopsy
Grading at
first biopsy
Grading at
follow-up biopsy
Time to follow-up
biopsy (months)
Treatment between
biopsies
Creatinine at
first biopsy
(mg per 100 ml)
Creatinin at
follow-up biopsy
(mg per 100 ml)
2 IV/IV 0 1, 2, 3, 4 116 CYC, CSA, MMF, Pred 1.3 0.8
11 II/IV 0 1, 2 23 No treatment 0.7 7.4
23 III/IV 1, 2 1, 2 36 CYC, CSA, AZA, MMF,
PP, Pred
3.1 9.8
39 WG/WG 1 2, 3 73 CYC, Pred 2.6 5.0
AZA, azathioprine; CSA, cyclosporine A; CYC, cyclophosphamide; MMF, mycophenolate mofetil; PP, plasma separation; Pred, prednisone; WG, Wegener’s granulomatosis.
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renal BCA-1/CXCL13 expression in the group of lupus
patients with abundant intrarenal B cells compared with the
remaining 11 patients without intrarenal B cells (Po0.01)
(Figure 7a). Similarly, mRNA was isolated from the six AAN
patients with the highest B-cell count (patient nos. 43–48)
as well as from the six patients with the lowest number
of intrarenal B cells (patient nos. 33–38). In line with
the observation in LN, mRNA analysis showed a signifi-
cantly higher BCA-1/CXCL13 expression (83.5±25.7-fold,
Po0.01) in B-cell-rich biopsy specimens compared with
those that contained no or only few B cells (Figure 7b).
DISCUSSION
In the last couple of years, numerous authors, including our
own group, have described the previously unrecognized
presence of intrarenal B cells in immunologically mediated
renal diseases, such as transplant rejection and glomerulone-
phritis.1–12 These B cells are exclusively detectable in the
tubulointerstitial compartment, but not in the glomerular
tuft.30 Many questions have arisen from these observations. It
would clearly be interesting to clarify the functional
importance of intrarenal B cells and the mechanisms leading
to their tissue infiltration. Because no functional data from
animal studies are available, several groups have correlated
the presence of intrarenal B cells with clinical outcome
measures such as serum creatinine or steroid resistance in
renal transplant rejection. The results of these retrospective
studies were inconclusive. Some investigators found deleter-
ious effects associated with intrarenal B cells in renal
transplant rejection,2,4–6 whereas others regarded the presence
or absence of B cells as irrelevant.18–20 These conflicting
results might on the one hand be explained by the small
numbers of patients included in the studies and their
retrospective character. However, one important aspect of
intrarenal B cells has not yet been investigated at all, namely
the grade of microanatomical organization. In previous
studies, inflamed kidneys were classified as containing no B
cells, B cells in a scattered pattern or B cells in the form of
clusters. This form of classification may not be accurate
enough because different organizational levels might have
different clinical implications. Therefore, our present mor-
phological study was aimed to characterize B-cell infiltrates
in lupus and AAN and to classify the infiltrates according to
their microanatomical structures. Characteristic and func-
tionally important hallmarks of lymph follicles in secondary
lymphatic tissues are distinct and separate T- and B-cell zones
and a central network of fDCs. To assess potential similarities
of intrarenal aggregates that contain these follicles, we
performed immunostaining using the pan B-cell marker
CD20, the pan T-cell marker CD3, and CD21 as a marker for
fDCs. Analysis of 32 biopsy specimens from patients with LN
and 16 patients with AAN revealed four different subgroups
of infiltrates with increasingly organized structures. Whereas
scattered B-cell infiltrates (grade 1) were mainly found in the
renal cortex but occasionally also seen in the medulla, grades
2–4 aggregates were exclusively found in the cortex. The
BCA-1
CD3
CD20
CD3
CD20BCA-1
BCA-1
Figure 5 | Intrarenal expression of BCA-1/CXCL13. Serial staining for B cells (CD20), T cells (CD3), and the lymphoid chemokine
BCA-1/CXCL13 showed exclusive BCA-1 expression in B-cell areas for both lupus nephritis (a) and AAN (b) (all original magnifications  200).
(c) A BCA-1-producing cell with typical dendritic morphology is shown (original magnification  1000).
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highest organizational grade seen in four lupus biopsy
specimens and in one AAN kidney contained clearly separate
T- and B-cell zones with a central fDC network. In less-
organized aggregates (grades 1–3), only little proliferation was
detected by staining for MIB-1. This argues for infiltration of
B cells from the circulation into the kidney. However, a
proliferating center around a network of fDCs was found in
clusters of the highest organizational level (grade 4). Unlike B
cells surrounding the proliferating center, the central B cells
did not express IgD. This exactly mirrors the situation in
germinal centers of lymphatic organs in which B cells lose
IgD expression upon entry into the germinal center. Here B
cells undergo affinity maturation, differentiation, and pro-
liferation. Our data therefore provide evidence for a local,
intrarenal outpost of the immune system that makes it
unnecessary for leukocytes to leave the kidney and migrate
toward the lymph nodes and spleen. Local proliferation in
these germinal centers might lead to the expansion and
perpetuation of inflammatory cell aggregates that could result
in persistence and chronicity of the renal inflammation.
As it is completely unclear via which routes lymphocytes
enter the observed intrarenal lymphatic aggregates, we
performed immunostaining for CD62L, which is a marker
for high endothelial venules. These highly specialized vessels
are specific routes of entry for lymphocytes into lymph nodes
and could therefore also play a role in the entry of
lymphocytes into the kidney. However, no CD62L-expressing
venules were found, arguing for different, still unknown
mechanisms.
For further examination of the possible mechanisms that
might lead to B-cell cluster formation, we performed
immunohistochemical staining of biopsy samples for BCA-
1/CXCL13. The chemokine BCA-1/CXCL13, which acts via
the chemokine receptor CXCR5 on B cells, is one of the most
potent B-cell chemoattractants31 and is one of the key players
in lymphoid organogenesis.32–34 We previously showed that
BCA-1/CXCL13 was associated with the formation of B-cell
clusters in acute interstitial and vascular transplant rejec-
tion.4,12 Here, we could demonstrate a strong BCA-1/
CXCL13 expression that is exclusively localized to regions
of B-cell infiltration irrespective of the organizational level.
Areas without CD20-positive B cells stained completely
negative for BCA-1/CXCL13. Similarly, positivity for the
corresponding receptor CXCR5 was specifically found in
B-cell regions, whereas all other resident and infiltrating cells
CXCR5
CD3
CD20
CD20CXCR5
CD3
Figure 6 | Expression of chemokine receptor CXCR5. Serial
staining for B cells (CD20), T cells (CD3), and the chemokine
receptor CXCR5 showed exclusive CXCR5 expression in B-cell
areas for both lupus nephritis (a) and AAN (b) (all original
magnifications  200).
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Figure 7 | Quantification of intrarenal BCA-1/CXCL13 mRNA
expression. Analysis of intrarenal BCA-1/CXCL13 mRNA
expression by real-time PCR from formalin-fixed biopsies revealed
a massive upregulation in B-cell containing biopsies as compared
with those without (a: 107.7±34.1-fold for lupus nephritis and
b: 83.5±25.7-fold for AAN, both Po0.01).
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stained negative. Analysis of RNA from sections of formalin-
fixed biopsy specimens underlined the association of BCA-1/
CXCL13 with B cells. Sections with high B-cell numbers from
patients with LN contained 107.7-fold more BCA-1/CXCL13
RNA in comparison with biopsies from LN patients without
B-cell infiltration and B-cell-positive sections from AAN
patients contained 83.5-fold more BCA-1/CXCL13 as com-
pared with the B-cell-negative group. It is therefore likely that
locally produced BCA-1/CXCL13 plays a functional role in
the infiltration of CXCR5-bearing B cells in LN and AAN.
The second chemokine, which is known to be crucially
implicated in lymphocyte homing to lymphoid tissues, is
SLC/CCL21 acting via its receptor CCR7.33,34 SLC/CCL21-
positive lymphatic vessels were present in high numbers in
biopsies of all grades. They were not only found in the
proximity of B-cell clusters but also in regions without B-cell
infiltration. Therefore, as Kerjaschki et al. and our own
group3,4,12 have previously shown in acute transplant
rejection, newly formed SLC/CCL21-positive lymphatic
vessels are widely distributed in the inflamed kidney but
are not specifically associated with B cells. The role for SLC/
CCL21 is still unclear and rewards further investigation.
Another aspect that has not yet been examined in detail is
the characterization of intrarenal B-cell subgroups with regard
to their grade of maturation, their ability for antibody
production, and antigen presentation. Our studies revealed
the absence of CD10-positive pre-B cells and only sparse
presence of CD27-positive and IgD-negative memory B cells
in LN and AAN specimens of all microanatomical levels of
organization. Plasma cells were also almost totally absent from
clusters of grades 2–4 and were usually found in a scattered
distribution in both, LN and AAN. Another possible function
of intrarenal B cells, especially those in cluster-forming units
that are in close proximity to numerous other leukocyte
subsets, is antigen presentation and activation of surrounding
immune cells such as T cells. The MHC class II receptor is
characteristic of cells that are professional antigen presenters.
These professional antigen-presenting cells take up antigens
very efficiently and use their MHC class II receptors to present
processed antigen fragments to CD4-positive helper T cells,
which are thereby activated. All other cells, including T cells,
do not express MHC class II receptors but use MHC class I
instead to present antigen that cannot activate T-helper cells.
Staining for the MHC class II complex revealed strong
positivity in intrarenal B-cell regions. This finding has not
been described before and may be seen as an indicator of the
function of intrarenal B cells as antigen presenters.
In several previous studies, a distinct subset of B cells,
termed B-1 cells, which are positive for the pan T-cell marker
CD5, has been identified. This specific subgroup was shown
to be more frequent in the blood of patients with systemic
lupus erythematosus28 and was linked to autoantibody
production independent of T-cell activation.29 Furthermore,
aberrant homing of B1 cells to inflamed organs, including the
kidneys, has been shown in a mouse model of systemic lupus
erythematosus.35 To test whether these cells are present in the
kidneys, we performed CD5 staining. Our analysis, however,
showed positive staining only in T-cell areas, whereas no
signal was seen in B cell areas. These results show that the
majority of intrarenal B cells, regardless of the organizational
grade, are of the mature B2, non-antibody-secreting pheno-
type with antigen-presenting ability.
To test whether the observed lymphoid aggregates under-
go progressive organization over time by which, for example,
a grade 2 aggregate could progress to a grade 4 aggregate, we
analyzed follow-up biopsies from three patients with LN and
one patient with AAN. Interestingly, in spite of immuno-
suppressive therapy in three cases, the aggregates had not
resolved in any of the four patients. In three of these four
patients, aggregates of higher organizational levels were
present at the later time points, whereas the aggregates
found in the fourth patient after therapy were still of the
same grades as before. These findings suggest a progressive
organizational process of intrarenal lymphatic structures over
time. The currently available immunosuppressants do not
seem to have a sufficient effect on formation of intrarenal
ectopic lymphoid tissue. This might be one of the reasons for
chronic manifestation and recurrent flares of LN and AAN.
It would be very interesting to study correlations between
clinical parameters and the presence of the four different
intrarenal lymphoid aggregates discussed here. However, to
do this, a larger number of patients than included in this
study would be needed to ensure sufficient statistical power.
In summary, our study revealed the presence of intrarenal
lymphoid structures of four different organizational stages. In
spite of immunosuppressive therapy, these aggregates did not
resolve but instead showed higher organizational levels. The
most organized aggregates closely resemble secondary
lymphatic tissue with fDC networks and proliferative centers.
Characterization of contributing B-cell populations revealed
that most of the B cells in all cluster types were of a mature,
non-antibody-secreting phenotype with the ability of antigen
presentation and helper T-cell activation via MHC class II
receptors. Their distribution was strongly correlated with
intrarenal expression of the lymphoid chemokine BCA-1/
CXCL13 by cells of a dendritic cell-like morphology and most
B cells were positive for the corresponding receptor CXCR5.
A role for this chemokine/chemokine receptor pair in B-cell
infiltration is therefore likely. The clinical impact of this
intrarenal lymphoid tissue is still unclear. However, our
proposal for a new and more detailed classification of
intrarenal lymphoid clusters might help to explain some of
the contradictory results from previous reports and could
help to shed some more light on the function of intrarenal B
cells in future studies.
MATERIAL AND METHODS
Patients and tissue samples
The study was conducted in accordance with the Declaration
of Helsinki Principles and with approval from the local ethics
committee. Renal biopsy samples were obtained from the
archive of the Department of Pathology of the University
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Hospital of Hamburg Eppendorf. Only patients in whom
systemic lupus erythematosus or AAN (Wegener’s disease or
microscopic polyangiitis) had been diagnosed in our center
between 1992 and 2003 were included in the study. The same
biopsy specimens were used for immunohistochemistry and
preparation of mRNA. Clinical classification of renal
pathologies was carried out by one single nephropathologist.
Follow-up biopsies after specific treatment were available in
three cases with LN and in one case with AAN. Clinical data
of the patients were obtained retrospectively from the records
of our center.
Immunohistochemistry
The following antibodies were used for immunohistochem-
ical staining: CD20 (L26, Dako; Glostrup, Denmark), CD3
(N1580; Dako), MIB-1 (dia 505; Dianova, Hamburg,
Germany), CD138 (VS38c; Dako), IgD (A0093; Dako),
BCA-1/CXCL13 (AF801; R&D System, Wiesbaden, Germany),
SLC (AF 366; R&D System), CXCR5 (51505; R&D System),
CD10 (56C6; Dianova), CD62L (MEKA-79, Becton
Dickinson, Heidelberg, Germany), CD5 (4C7; Novocastra,
Newcastle, UK), MHC class II (CR3/43; Dako), CD21 (1F8;
Dako), and CD27 (137B4; Dianova).
Formalin-fixed, paraffin-embedded tissue sections (2mm)
were deparaffinized and rehydrated through graded ethanol
solutions. Antigen retrieval for staining with CD3, CD5, CD10,
CD20, CD62L, BCA-1, SLC, and CD138 was achieved by
placing sections in citrate buffer (pH 6.1) and heating in the
microwave for 25 min. In the case of IgD, sections were placed
in citrate buffer at pH 9.0 and heated in the microwave for
10 min. For staining with CD21, CD27, and CXCR5, samples
were pre-treated in an autoclave for 15 min. For staining with
the MHC class II antibody, sections were pre-treated with
protease for 30 min. Sections were incubated with most primary
antibodies for 30 min with the exception of CD10, CXCR5, and
BCA-1 with which biopsies were incubated overnight. Tissue
sections were developed with the Vectastain ABC-AP kit (Vector
Laboratories, Burlingame, CA, USA) as described.36
Grading of biopsies
Renal biopsies were classified according to the organizational
stage of inflammatory cell infiltrates. Four distinct categories
could be distinguished. A scattered pattern of intrarenal
CD20þ B cells was graded as 1. Nodular aggregates consisting
of CD3-positive T cells and B cells without microanatomical
compartmentalization were graded as 2. In the case of clearly
separated T-cell and B-cell zones without a central dendritic
cell network, aggregates were classified as 3. Aggregates with
the highest level of microanatomical organization, consisting
of separated T- and B-cell compartments with a central
network of CD21þ fDCs were classified as 4. Biopsies with
no intrarenal CD20þ B cells were graded as 0.
Preparation of total RNA from formalin-fixed tissue
For preparation of total RNA, the High Pure FFPE RNA kit
(Roche, Mannheim, Germany) was used. Two 10-mm-thick
sections from archived formalin-fixed and paraffin-
embedded tissue samples were placed in a 1.5-ml reaction
tube. Deparaffination was carried out by incubation in Xylol
with subsequent washing steps in 100% and 70% ethanol.
Lysis of the tissue pellet was then carried out by adding 60 ml
of the specific lysis buffer with 10 ml of 10% sodium dodecyl
sulfate. Afterward, 30 ml of Proteinase K were added and the
probes were incubated for 3 h at 55 1C. After centrifugation,
200 ml of binding buffer and 200 ml of 100% ethanol were
added and the lysate was allowed to bind to the specific High
Pure Micro Filter Tube assembly. Hereafter, the columns were
incubated for 15 min at room temperature in DNase solution
followed by three washing steps. The final elution of total
RNA was carried out in a volume of 30 ml elution buffer.
Real-time PCR analysis
RNA of the formalin-fixed biopsy tissue was isolated as
described above. Total RNA was reverse transcribed using the
Taqman Reverse Transcriptase Kit (Applied Biosystems,
Foster City, CA, USA). Real-time PCR analysis was
performed in the ABI-Prism 7000 Sequence Detection System
(Applied Biosystems) as described before.36 The following
human PCR primers were used:
hBCA-1.3: GCAGCCTCTCTCCAGTCCAA
hBCA-1.4: TGGACACATCTACACCTCAAGCTT
All specific amplicons were normalized against ribosomal
RNA (18 s).
Statistical analysis
Data are presented as mean±s.d. Relative expression of
BCA-1/CXCL13 in the two groups was compared by the
Mann–Whitney U-test. All statistical analyses were carried
out using the SPSS 10.1 software.
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